The National Institute for Health and Care Excellence (NICE) have published draft guidance for consultation on decision making and mental capacity. The guidance aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so, and to help practitioners to keep people who lack capacity at the centre of the decision-making process. The consultation on the guideline, and economic model, is open to 5 February 2018.
The Centre for Health Economics (CHE) at the University of York have published a scoping review on social care economic evaluation methods. A systematic review of the published literature and a survey of experts were undertaken to inform NICE on the methods available for use in undertaking economic evaluation of social care interventions, and the methods in development, the challenges faced and the methods gaps.
The PharmacoEconomics journal has a supplement issue on estimating utility values for economic evaluation. The supplement is volume 35, issue 1 supplement, December 2017. The full list of articles is listed below, the journal is available in full text but may require a login off-campus.
Editorial: Heath State Utility Values for Cost-Effectiveness Models / Jonathan Karnon
Editorial: Special Edition on Utility Measurement, PharmacoEconomics / Andrew Lloyd
Commentary: Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care / Roberta Ara, Tessa Peasgood, Clara Mukuria, Helene Chevrou-Severac…
International Regulations and Recommendations for Utility Data for Health Technology Assessment / Donna Rowen, Ismail Azzabi Zouraq, Helene Chevrou-Severac…
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models / John Brazier, Roberta Ara, Donna Rowen, Helene Chevrou-Severac
The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment / Donna Rowen, John Brazier, Roberta Ara, Ismail Azzabi Zouraq
The Identification, Review and Synthesis of Health State Utility Values from the Literature / Roberta Ara, John Brazier, Tessa Peasgood, Suzy Paisley
The Use of Mapping to Estimate Health State Utility Values / Roberta Ara, Donna Rowen, Clara Mukuria
Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies / Roberta Ara, John Brazier, Tracey Young
The Use of Health State Utility Values in Decision Models / Roberta Ara, John Brazier, Ismail Azzabi Zouraq
Estimating Health State Utility Values for Comorbidities / Roberta Ara, John Brazier
A report by HERU authors has been published by Food Standards Scotland. The report provides a review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-related illness.
McNamee, P., Neilson, A., Norwood, P., Avenell, A. and Ludbrook, A. (2017) ‘A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-related illness’, Aberdeen: Food Standards Scotland.
The York Health Economics Consortium (YHEC) have produced a literature review on behalf of the British Lung Foundation and the British Thoracic Society on the economic costs of lung disease and the cost-effectiveness of different NHS activities, programmes and campaigns to combat lung problems.
Public Health England have developed a health economic evidence resource (HEER) tool to show the key cost-effectiveness and return on investment evidence on public health activities. The tool is designed to provide an initial ‘snapshot’ of the economic evidence underpinning public health interventions. There are nine areas of public health activity including obesity and physical activity; alcohol misuse; and smoking and tobacco use. Short summaries of the intervention and a link to the original source are included.
The National Institute for Health and Care Excellence (NICE) have issued a position statement on the use of the EQ-5D-5L valuation set. The statement recommends not using the 5L valuation set for evidence submissions to NICE that use cost-utility analyses. Preference should be given to the EQ-5D-3L valuation set. The full statement gives more detail on the decision from the NICE Decision Support Unit.